Raymund Razonable to Administration, Intravenous
This is a "connection" page, showing publications Raymund Razonable has written about Administration, Intravenous.
Connection Strength
0.169
-
Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19. J Clin Invest. 2021 10 01; 131(19).
Score: 0.169